I’ve seen firsthand how devastating Alzheimer’s can be — not just for the individuals living with it but also for their loved ...

In the stillness of the night, when the body should lie calm in sleep, something else may be happening beneath the surface.

There’s at least a 1 in 10 chance when you are 65 years old that you’ll develop Alzheimer’s in your lifetime—a sobering ...

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...

Learn to spot and avoid common scams with the help of AARP's Fraud Resource Center. Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental A 3 a.m. phone call to a dementia ...

The shingles vaccine reduced dementia risk by 20 percent in a recent study. The vaccine’s protective effect against dementia was more pronounced in women. Shingles vaccination is recommended for ...

Harvard researchers have pinpointed over a dozen risk factors for dementia and other brain disorders - and all of them are preventable. Researchers at Mass General Brigham analyzed 37 studies on ...

That’s according to a new study from Mass General Brigham (MGB), which identified 17 common risk factors all linked to stroke, dementia and late-life depression. The researchers combed through ...

A man whose wife is living with early onset dementia has spoken out about the first symptom he noticed prior to her diagnosis. Husband and wife John and Heather, from Halifax, Canada, decided to ...

"Dementia" is a broad term for cognitive disorders affecting memory, reasoning, and behavior. As dementia progresses, it can become increasingly difficult for patients to carry out everyday tasks ...

A new study has found a link between 'bad' cholesterol and the risk of dementia. It suggests that common cholesterol-lowering medicines, like statins, can help protect brain health as we age, even in ...

Overall, glucose-lowering therapy was not significantly associated with a reduction in all-cause dementia or cognitive impairment. Treatment with glucagon-like peptide-1 receptor agonists (GLP ...